Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using In Vitro Experiments and Response …

C Genestet, F Ader, C Pichat, G Lina… - Antimicrobial Agents …, 2018 - Am Soc Microbiol
While isoniazid and rifampin have been the cornerstone of tuberculosis therapy caused by
drug-susceptible Mycobacterium tuberculosis for more than 40 years, their combined action …

Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using In Vitro Experiments and Response-Surface …

C Genestet, F Ader, C Pichat, G Lina… - Antimicrobial Agents …, 2017 - europepmc.org
While isoniazid and rifampin have been the cornerstone of tuberculosis therapy caused by
drug-susceptible Mycobacterium tuberculosis for more than 40 years, their combined action …

Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using In Vitro Experiments and Response-Surface …

C Genestet, F Ader, C Pichat, G Lina… - Antimicrobial Agents …, 2018 - hero.epa.gov
While isoniazid and rifampin have been the cornerstone of tuberculosis therapy caused by
drug-susceptible Mycobacterium tuberculosis for more than 40 years, their combined action …

Assessing the combined antibacterial effect of isoniazid and rifampin on four Mycobacterium tuberculosis strains using in vitro experiments and response-surface …

C Genestet, F Ader, C Pichat, G Lina, O Dumitrescu… - 2018 - cabidigitallibrary.org
While isoniazid and rifampin have been the cornerstone of tuberculosis therapy caused by
drug-susceptible Mycobacterium tuberculosis for more than 40 years, their combined action …

Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using In Vitro Experiments and Response-Surface …

C Genestet, F Ader, C Pichat, G Lina… - Antimicrobial Agents …, 2018 - hal.science
While isoniazid and rifampin have been the cornerstone of tuberculosis therapy caused by
drug-susceptible Mycobacterium tuberculosis for more than 40 years, their combined action …

Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using In Vitro Experiments and Response-Surface …

C Genestet, F Ader, C Pichat, G Lina… - Antimicrobial …, 2017 - pubmed.ncbi.nlm.nih.gov
While isoniazid and rifampin have been the cornerstone of tuberculosis therapy caused by
drug-susceptible Mycobacterium tuberculosis for more than 40 years, their combined action …

[HTML][HTML] Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using In Vitro Experiments and Response …

C Genestet, F Ader, C Pichat, G Lina… - Antimicrobial Agents …, 2018 - ncbi.nlm.nih.gov
While isoniazid and rifampin have been the cornerstone of tuberculosis therapy caused by
drug-susceptible Mycobacterium tuberculosis for more than 40 years, their combined action …

Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using In Vitro Experiments and Response-Surface …

C Genestet, F Ader, C Pichat, G Lina… - Antimicrobial Agents …, 2017 - europepmc.org
While isoniazid and rifampin have been the cornerstone of tuberculosis therapy caused by
drug-susceptible Mycobacterium tuberculosis for more than 40 years, their combined action …